A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...

A new nationwide analysis is shedding light on how states compare when it comes to a major public health challenge, and the ...

Today, we're putting a super popular workout under the microscope: CrossFit. And we're tackling a big question: Is it the ...

Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.

Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...

Hypertension in adolescents (aged 10–19 years) and young adults is becoming a major global health issue, largely due to ...

California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program. Instead, the state opted to include them. Under Newsom’s proposed cuts, when Ozempic is ...

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...